Clinical Trial: Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157007) titled 'Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19' on Sept. 03.

Brief Summary: This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19. It will also learn about the safety of drug Ratutrelvir. Participants will take a study drug as well as a standard therapy. A descriptive statistics will be used to present the study results.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: COVID - 19

Intervention: DRUG: Ratutrelvir (83-0060) non-randomised

83-0060, a covalent inh...